A rapid enzyme-linked assay for ADAMTS-13

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 1, 2006, Pages 129-136

  Wu, J J ^a   Fujikawa, K ^a   Lian, E C ^b   McMullen, B A ^a   Kulman, J D ^a   Chung, Dominic W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Biotinylation; Enzyme linked assay; Horseradish peroxidase conjugation

Indexed keywords

AGAROSE; BIOTIN; HORSERADISH PEROXIDASE; METHIONINE; PROTEIN ANTIBODY; STREPTAVIDIN; TYROSINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; PEPTIDE FRAGMENT;

AMINO TERMINAL SEQUENCE; ANTIBODY TITER; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INCUBATION TIME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; BIOTINYLATION; BLOOD; ENZYME ASSAY; METABOLISM; METHODOLOGY; PHOTOMETRY; SENSITIVITY AND SPECIFICITY; STANDARD; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; BINDING SITES; BIOTINYLATION; ENZYME TESTS; HORSERADISH PEROXIDASE; HUMANS; PEPTIDE FRAGMENTS; PHOTOMETRY; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33644862000     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01677.x     Document Type: Article

References (22)

1. Moake JL. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Hematol 2004; 41: 4-14.
2. Furlan M, Robles R, Lamie B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996; 87: 4223-34.
3. Tsai H-M. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996; 87: 4235-44.
4. Gerritsen H, Robles R, Lammle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 2001; 98: 1654-61.
5. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloprotease family. Blood 2001; 98: 1662-6.
6. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw Jr JD, Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-94.
7. Dent J, Berkowitz S, Ware J, Kasper C, Ruggeri Z. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 1990; 87: 6306-10.
8. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle P, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
9. Tsai HM, Lian E. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 585-94.
10. Remuzzi G. Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No. J Thromb Haemost 2003; 1: 632-634.
11. Tsai HM. Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes. J Thromb Haemost 2003; 1: 625-31.
12. Gerritsen H, Turecek P, Schwarz H, Lammle B, Furlan M. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thromb Haemost 1999; 82: 1380-1.
13. Bohm M, Vigh T, Scharrer I. Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13). Ann Hematol 2002; 81: 430-435.
14. Obert B, Tout H, Veyradier A, Fressinaud E, Meyer D, Girma J. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF. Thromb Haemost 1999; 82: 1382-5.
15. Kokame K, Matsumoto M, Fujimura Y, Miyata T. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood 2004; 103: 607-12.
16. Zhou W, Tsai HM. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations. Thromb Haemost 2004; 91: 806-11.
17. Whitelock J, Nolasco L, Bernardo A, Moake J, Dong J, Cruz MA. ADAMTS-13 activity in plasma is rapidly measured by a new ELISA method that uses recombinant VWF-A2 domain as substrate. J Thromb Haemost 2004; 2: 485-91.
18. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETs-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005; 129: 93-100.
19. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
20. Tripodi A, Chantarangkul V, Bohm M, Budde U, Dong J, Friedman K, Galbusera M, Girma J, Moake J, Rick M, Studt J, Turecek P, Mannucci P. Measurement of von Willebrand factor cleaving protease (ADAMTS-13): Results of an international collaborative study involving 11 methods testing the same set of coded plasmas. J Thromb Haemost 2004; 2: 1601-9.
21. Knobl P, Haas M, Laczika K, Varadi K, Turecek PL. Immunoadsorption for the treatment of a patient with severe thrombotic thrombocytopenic purpura resistant to plasma exchange: Kinetics of an inhibitor of ADAMTS13. J Thromb Haemost 2003; 1: 187-9.
22. Crawley JT, Lam JK, Rance JB, Mollica LR, O'Donnell JS, Land DA. Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood 2005; 105: 1085-93.